A knock-out of TNFR in mice has already been repeatedly associated with reduced nociceptive responses in models of inflammatory, cancer, and neuropathic pain [35–37] and might thus cover antinociceptive effects mediated by TBK1 knock-down. The gene discussed is TNFRSF1A; the disease is cancer.